We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

BBRI:IDXPT Bank Rakyat Indonesia (Persero) Tbk Class B Analysis

Data as of 2026-03-13 - not real-time

IDR 3,510.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

BBRI is trading at IDR 3,510, touching its 20‑day SMA and lying below the 50‑day SMA, indicating short‑term weakness. The 14‑day RSI of 33 suggests the stock is approaching oversold territory. MACD shows a bearish divergence with the histogram at –35, reinforcing downward momentum. Yet the price remains above the identified support of 3,510 and well below the 200‑day SMA of 3,864, highlighting a sizeable upside potential of ~24% to the median analyst target. Valuation metrics are compelling: a trailing P/E of 9.3 is far below the industry average of 16.4, and the price‑to‑book of 1.63 reflects a modest premium to book value. The dividend yield of 9.68% is among the highest in the sector, though the payout ratio sits at 92%, raising questions about sustainability.
Recent news confirms a dividend payout on 15 Jan 2026 and notes that Moody’s has revised the outlook for major Indonesian banks to negative, adding a regulatory headwind. Despite the downgrade, the Financial Services Authority (OJK) reassured that the banking sector’s fundamentals remain solid. The stock’s beta of 0.37 and a 30‑day volatility of 27% point to relatively low systematic risk but elevated price swings. Volume has been decreasing, which may limit short‑term buying pressure. Overall, the combination of attractive valuation, high yield, and a clear technical support level makes the stock a candidate for value‑oriented investors. However, the bearish technical backdrop and regulatory uncertainty suggest caution in timing.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish technical indicators (RSI, MACD)
  • Price at key support level
  • High dividend yield but sustainability concerns

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued relative to industry P/E
  • Attractive dividend yield
  • Potential upside to analyst price targets

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Strong market position in Indonesia
  • Stable regulatory environment per OJK
  • Dividend sustainability risk balanced by solid fundamentals

Key Metrics & Analysis

Financial Health

Revenue Growth17.00%
Profit Margin40.41%
P/E Ratio9.3
ROE17.46%
ROA2.77%
P/B Ratio1.6
Op. Cash FlowIDR-89698663923712
Industry P/E16.4

Technical Analysis

TrendBearish
RSI33.0
SupportIDR 3,510.00
ResistanceIDR 3,980.00
MA 20IDR 3,755.00
MA 50IDR 3,760.80
MA 200IDR 3,863.75
MACDBearish
VolumeDecreasing
Fear & Greed Index72.13

Valuation

Target PriceIDR 4,353.41
Upside/Downside24.03%
GradeUndervalued
TypeBlend
Dividend Yield9.68%

Risk Assessment

Beta0.37
Volatility26.99%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.